(Date:7/25/2008)...5.7%, ORANGE COUNTY, Calif., July 25 /PRNewswire-... a leading developer, manufacturer and marketer,of...plex biomedical,testing, announced today second qu...Total revenue of $798.3 million increased 15.7% ov...nue was up 11.2%. Net earnings were,$47.8 million,...
(Date:7/24/2008)...ire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; OTC: MGIF...ious,diseases, advises that the directors of MIGEN...ers (the "Meeting") to be held at 2:00 p.m. (Vanco...th Sciences Mall, Vancouver,British Columbia. Fur...rovided in an Information Circular to be prepared ...
(Date:7/24/2008)...irstCall/ -- Abaxis, Inc.,(Nasdaq: ABAX ), a medi...lood analysis systems, today reported financial re...2008., Quarterly highlights include: -- Revenu...able quarter. -- Total sales of chemistry and hem...r 19% over last year,s comparable quarter. -- Vet...
(Date:7/24/2008)...mbedded with a telescope,promise to make it easier...ther activities requiring sharper distance vision....be the advantages of these innovative glasses,over...y/June issue of,Journal of Biomedical Optics, mail...s new design has several advantages," says the inv...
Breaking Biology Technology:Beckman Coulter Announces Second Quarter 2008 Results 2Beckman Coulter Announces Second Quarter 2008 Results 3Beckman Coulter Announces Second Quarter 2008 Results 4Beckman Coulter Announces Second Quarter 2008 Results 5Beckman Coulter Announces Second Quarter 2008 Results 6Beckman Coulter Announces Second Quarter 2008 Results 7Beckman Coulter Announces Second Quarter 2008 Results 8Beckman Coulter Announces Second Quarter 2008 Results 9Beckman Coulter Announces Second Quarter 2008 Results 10Beckman Coulter Announces Second Quarter 2008 Results 11Beckman Coulter Announces Second Quarter 2008 Results 12Beckman Coulter Announces Second Quarter 2008 Results 13Beckman Coulter Announces Second Quarter 2008 Results 14Beckman Coulter Announces Second Quarter 2008 Results 15Beckman Coulter Announces Second Quarter 2008 Results 16Beckman Coulter Announces Second Quarter 2008 Results 17Beckman Coulter Announces Second Quarter 2008 Results 18Beckman Coulter Announces Second Quarter 2008 Results 19Beckman Coulter Announces Second Quarter 2008 Results 20Beckman Coulter Announces Second Quarter 2008 Results 21Beckman Coulter Announces Second Quarter 2008 Results 22Beckman Coulter Announces Second Quarter 2008 Results 23Beckman Coulter Announces Second Quarter 2008 Results 24Beckman Coulter Announces Second Quarter 2008 Results 25Beckman Coulter Announces Second Quarter 2008 Results 26Beckman Coulter Announces Second Quarter 2008 Results 27Beckman Coulter Announces Second Quarter 2008 Results 28Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 8Telescope Embedded in Spectacle Lens Promises to Make Driving Easier for Visually Impaired 2...ses today are focused on being profitable and prod...days, months and years, you,ll see an increase in ...ze businesses, as well as mid-to-large-size commer...orate technology to add efficiency to their busine...rs. , ,There are several new federal and state r...
...EE Catalyst International, a global provider of s...panded its suite of platform-independent SCE appli...E solution suite to meet customers, increasing dem...lier to end user, regardless of platform or bounda...talyst. , ,Catalyst has adopted Open Application ...
... 13th straight year, Wisconsin scored an A for eco...ise Development released its annual report card on... as glowing, as the Wisconsin Technology Networks...ewed concerns about the states ability to foster e...tplace. , ,Wisconsin is an innovative state. It ha...
...N, WI Nearly 60 people heard UW-Madison professor...lopment manager David Matthias stress the importan...eting of the Wisconsin Innovation Network (WIN) Fo...tion is the membership subsidiary of the Wisconsin...-profit science and technology advisor to the gove...
Other Biology Technology:Doing it Right: Business IT Fusion for the Future 2Doing it Right: Business IT Fusion for the Future 3Grow Wisconsin Should Help Tutor Wisconsin on Economic Growth 2WIN Northeast Wisconsin Chapter Launched for Regions Entrepreneurs 2(Date:7/23/2008)...tudy Finds Some Areas of the Body Have Greater Con...., July 23 /PRNewswire-USNewswire/ -- Fat removed,...osuction was found to be,an excellent source of st...n other areas of the body, reports a Brazilian-bas...rgery(R), the official medical journal of the,Amer...
(Date:7/22/2008)...NE, Australia, July 22 /- F...terday, the Board of Progen,Pharmaceuticals Limite...,had discontinued the PI-88 phase 3 study in liver...to develop its existing portfolio of compounds and...nal compounds and,opportunities through Merger & A...
(Date:7/22/2008)... Meeting to Discuss Development Plan Completed Suc...irstCall/ -- Amarin Corporation,plc (NASDAQ: AMRN...ith,officials at the U.S. Food and Drug Administra...op AMR101 for the treatment of,hypertriglyceridemi...ceeding to Phase 3 with AMR101 in hypertriglycerid...
(Date:7/22/2008)...ffrey Allan Will Stress the Importance to Patients... Approval Pathway, RICHMOND, Va., July 22 /PRNews... developer of follow-on biologics and biopharmaceu..., CEO of Insmed, will present at a,Congressional b...significant need for establishing an approval path...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Protecting Productivity at the Worksite in Challenging Times 10589 1Protecting Productivity at the Worksite in Challenging Times 10589 2Oncolytics Biotech Inc Proceeds to Full Enrolment in U S Phase II Sarcoma Clinical Trial 2875 1Oncolytics Biotech Inc Proceeds to Full Enrolment in U S Phase II Sarcoma Clinical Trial 2875 2Oncolytics Biotech Inc Proceeds to Full Enrolment in U S Phase II Sarcoma Clinical Trial 2875 3The HLA DRB1 gene and premature death in rheumatoid arthritis 10584 1The HLA DRB1 gene and premature death in rheumatoid arthritis 10584 2The HLA DRB1 gene and premature death in rheumatoid arthritis 10584 3New adhesive mimics gecko toe hairs 2870 1New adhesive mimics gecko toe hairs 2870 2New adhesive mimics gecko toe hairs 2870 3...TTLE--(BUSINESS WIRE)--Jun 1, 2007 - Introgen Ther...ase 1/2 clinical data with INGN,241, the Company,s...r agent, in patients with advanced solid tumors., ...ay at the,annual meeting of the American Society o...al, INGN 241 induced killing in all treated,tumors...
...TRÉAL, June 1, 2007 – Thallion Pharma...liminary data from its Phase,I/II clinical trial i...was published in abstract form as part of the Amer...eting in Chicago,Illinois. In the Phase I dose es...lorectal, two ovarian, one duodenal and one,glioma...
Other Medicine Technology:Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 2Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors 3Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3